BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18482042)

  • 1. Successful treatment of recalcitrant pemphigus foliaceus with rituximab.
    Serrão VV; Martins A; Páris FR; Lopes MP
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):768-70. PubMed ID: 18482042
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab).
    Marzano AV; Fanoni D; Venegoni L; Berti E; Caputo R
    Dermatology; 2007; 214(4):310-8. PubMed ID: 17460402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed response of oral pemphigus vulgaris to rituximab treatment.
    Niedermeier A; Wörl P; Barth S; Schuler G; Hertl M
    Eur J Dermatol; 2006; 16(3):266-70. PubMed ID: 16709491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
    Kong HH; Prose NS; Ware RE; Hall RP
    Pediatr Dermatol; 2005; 22(5):461-4. PubMed ID: 16191003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized erythrodermic pemphigus foliaceus in a child and its successful response to rituximab treatment.
    Connelly EA; Aber C; Kleiner G; Nousari C; Charles C; Schachner LA
    Pediatr Dermatol; 2007; 24(2):172-6. PubMed ID: 17461818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment failure with rituximab in a patient with pemphigus vulgaris.
    Weger W; Aberer E
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):387-9. PubMed ID: 18269618
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of refractory pemphigus erythematosus with rituximab.
    Diab M; Bechtel M; Coloe J; Kurtz E; Ranalli M
    Int J Dermatol; 2008 Dec; 47(12):1317-8. PubMed ID: 19126029
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
    Prodanovic EM; Korman NJ
    J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting remission of pemphigus vulgaris treated with rituximab.
    Esposito M; Capriotti E; Giunta A; Bianchi L; Chimenti S
    Acta Derm Venereol; 2006; 86(1):87-9. PubMed ID: 16586007
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab in refractory pemphigus vulgaris.
    Sorce M; Aricò M; Bongiorno MR
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S6-9. PubMed ID: 18727815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in severe pemphigus.
    Schmidt E; Goebeler M; Zillikens D
    Ann N Y Acad Sci; 2009 Sep; 1173():683-91. PubMed ID: 19758216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients.
    Goh MS; McCormack C; Dinh HV; Welsh B; Foley P; Prince HM
    Br J Dermatol; 2007 May; 156(5):990-6. PubMed ID: 17355229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab (anti-CD20 monoclonal antibody)--ultimate or first choice in pemphigus?
    Hertl M; Eming R; Borradori L
    Dermatology; 2007; 214(4):275-7. PubMed ID: 17460396
    [No Abstract]   [Full Text] [Related]  

  • 14. Rituximab for pemphigus vulgaris.
    Joly P; D'Incan M; Musette P
    N Engl J Med; 2007 Feb; 356(5):521; author reply 521-2. PubMed ID: 17267915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of severe refractory pemphigus vulgaris with rituximab].
    Pitarch G; Sánchez-Carazo JL; Pardo J; Torrijos A; Roche E; Fortea JM
    Actas Dermosifiliogr; 2006; 97(1):48-51. PubMed ID: 16540052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of pemphigus foliaceus with rituximab. Report of 3 cases].
    Alter M; Wittmann M; Völker B; Kapp A; Werfel T; Gutzmer R
    Hautarzt; 2009 Sep; 60(9):743-8. PubMed ID: 19151961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe pemphigus foliaceus with rituximab.
    Fernando SL; O'Connor KS
    Med J Aust; 2008 Sep; 189(5):289-90. PubMed ID: 18759729
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab.
    Schmidt E; Herzog S; Bröcker EB; Zillikens D; Goebeler M
    Br J Dermatol; 2005 Aug; 153(2):449-51. PubMed ID: 16086770
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab therapy in severe juvenile pemphigus vulgaris.
    Mamelak AJ; Eid MP; Cohen BA; Anhalt GJ
    Cutis; 2007 Oct; 80(4):335-40. PubMed ID: 18038698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab.
    Meijs M; Mekkes J; van Noesel C; Nijhuis E; Leeksma O; Jonkman M; Hoekzema R
    Int J Dermatol; 2008 Jun; 47(6):632-4. PubMed ID: 18477166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.